P

Pharmapulse

BE1008.309.951

About Pharmapulse

Pharmapulse is a general partnership (VOF/SNC) based in Lasne, founded in 2024. Its main activity is classified as "Activiteiten van uitzendbureaus en andere diensten in verband met personeelsvoorziening". For the 2025 financial year, Pharmapulse reported a loss of €6,479. A year earlier, in 2024, it still made a profit of €3,117. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €889,809, up 1,707% on 2024. It employed an average of 14.7 full-time equivalents. Equity is negative (-€2,362): liabilities exceed assets. 2 annual accounts are available, covering 2024 to 2025.

Juridical situation
Normal situation
Company number
1008.309.951
Founding date
Founded in 11-04-2024
EUID number
BEKBOBCE.1008.309.951
Type of enterprise
Rechtspersoon
Location
Rue De La Bachée 86 Lasne 1380
Juridical form
VOF — General partnership (VOF/SNC)
Signals
Negative equity
Reporting losses
Poor liquidity
Negative cashflow
Negative EBITDA
Healthy social debt

Frequently asked questions

Answers to the most common questions about Pharmapulse, based on official government data and the filed annual accounts.

What is the VAT number of Pharmapulse?

The VAT number of Pharmapulse is BE1008.309.951.

When was Pharmapulse established?

Pharmapulse was founded in 11-04-2024.

What is the official address of Pharmapulse?

The official address of Pharmapulse is Rue De La Bachée 86 Lasne 1380.

What is the legal form of Pharmapulse?

The juridical form of Pharmapulse is General partnership (VOF/SNC).

What is the annual revenue of Pharmapulse?

Pharmapulse has not (yet) filed an annual report, so there are no revenue figures available.

Is Pharmapulse a reliable company?

Pharmapulse is a registered Rechtspersoon with company number 1008.309.951 and can be verified through the official CBE database.

What is the credit limit of Pharmapulse?

The estimated credit limit of Pharmapulse is €0.

Is Pharmapulse still active?

Pharmapulse currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources